Successful Treatment with Rituximab in a Patient with Clinically Suspected Small-vessel Primary Central Nervous System Vasculitis Refractory to Cyclophosphamide Pulse Therapy.

Rituxan (rituximab) - Roche

cyclophosphamide - Generic mfg.

Successful Treatment with Rituximab in a Patient with Clinically Suspected Small-vessel Primary Central Nervous System Vasculitis Refractory to Cyclophosphamide Pulse Therapy. (PubMed, Intern Med) - Oct 1, 2026 - "This clinical improvement indirectly suggests B-cell involvement, consistent with the efficacy of rituximab. Rituximab may therefore be an option for treating cyclophosphamide-resistant PCNSV."
Journal • Alzheimer's Disease • CNS Disorders • Cognitive Disorders • Vasculitis • IL6

http://www.ncbi.nlm.nih.gov/pubmed/42816389

Bungo Hirose; Kazuki Yokokawa; Naotoshi Iwahara; Shin Hisahara; Syuuichirou Suzuki; Takuya Okamoto

Oct 1, 2026